Importantly, deflamin was effective in inhibiting MMP-2, MMP-9, and general ECM remodeling, favoring spatial constraints of tumor growth/progression and limited nutrient/oxygen supply, due to decreased angiogenesis. This evidence concerns the gene MMP2 and neoplasm.